Table 5.
Comparison of adverse reactions between the two groups (n, %)
| Adverse reactions | SG | CG | P |
|---|---|---|---|
| Nausea | 3 (4.76) | 4 (7.41) | 0.702 |
| Upper abdominal discomfort | 3 (4.76) | 3 (5.56) | > 0.999 |
| Palpitation | 4 (6.35) | 0 | 0.123 |
| Hypoglycemic reaction | 3 (4.76) | 0 | 0.248 |
Comparison of adverse reactions between the two groups (n, %)
| Adverse reactions | SG | CG | P |
|---|---|---|---|
| Nausea | 3 (4.76) | 4 (7.41) | 0.702 |
| Upper abdominal discomfort | 3 (4.76) | 3 (5.56) | > 0.999 |
| Palpitation | 4 (6.35) | 0 | 0.123 |
| Hypoglycemic reaction | 3 (4.76) | 0 | 0.248 |